Lindsay Goldberg completed the minority investment in CTI.

Synopsis

Lindsay Goldberg, a private equity firm, completed the minority investment in CTI, a clinical research organization in the pharmaceutical and biotechnology industry. Financial terms were not disclosed.

Principals

target

CTI

bidder

Lindsay Goldberg

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (2)

timothy schroeder

Chairman and CEO at CTI

Manager

target

Deal

n/a

Total Value

brian lawrence

CFO at CTI

Manager

target

Deal

n/a

Total Value

Bidder Team (2)

paul kukish

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 36.00 B

Total Value

alan e. goldberg

Founder and CEO at LINDSAY GOLDBERG

Investor

bidder

Deals

£ 1.00 B

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy